Metastatic progression is driven by the mutated form of the tumour-suppressor protein p53 (encoded in the human TP53 gene), as demonstrated in mice [3,4], human breast [5] and pancreatic cancers [6]. Here, TP53 is linked to pancreatic neoplasm.